Global and United States Rare Disease Diagnostics Market Report & Forecast 2023-2028

Report ID: 1830763 | Published Date: Oct 2024 | No. of Page: 88 | Base Year: 2023 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Rare Disease Diagnostics Revenue in Rare Disease Diagnostics Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Rare Disease Diagnostics Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Rare Disease Diagnostics Market Size for the Year 2017-2028
        1.2.2 Global Rare Disease Diagnostics Market Size for the Year 2017-2028
    1.3 Rare Disease Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Rare Disease Diagnostics in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Rare Disease Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Rare Disease Diagnostics Market Dynamics
        1.4.1 Rare Disease Diagnostics Industry Trends
        1.4.2 Rare Disease Diagnostics Market Drivers
        1.4.3 Rare Disease Diagnostics Market Challenges
        1.4.4 Rare Disease Diagnostics Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Rare Disease Diagnostics by Type
    2.1 Rare Disease Diagnostics Market Segment by Type
        2.1.1 Hematology
        2.1.2 Oncology
    2.2 Global Rare Disease Diagnostics Market Size by Type (2017, 2022 & 2028)
    2.3 Global Rare Disease Diagnostics Market Size by Type (2017-2028)
    2.4 United States Rare Disease Diagnostics Market Size by Type (2017, 2022 & 2028)
    2.5 United States Rare Disease Diagnostics Market Size by Type (2017-2028)
3 Rare Disease Diagnostics by Application
    3.1 Rare Disease Diagnostics Market Segment by Application
        3.1.1 Hospital Laboratories
        3.1.2 Diagnostic Laboratories
        3.1.3 Genetic Testing Laboratories
        3.1.4 Cancer Research Laboratories
        3.1.5 Others
    3.2 Global Rare Disease Diagnostics Market Size by Application (2017, 2022 & 2028)
    3.3 Global Rare Disease Diagnostics Market Size by Application (2017-2028)
    3.4 United States Rare Disease Diagnostics Market Size by Application (2017, 2022 & 2028)
    3.5 United States Rare Disease Diagnostics Market Size by Application (2017-2028)
4 Global Rare Disease Diagnostics Competitor Landscape by Company
    4.1 Global Rare Disease Diagnostics Market Size by Company
        4.1.1 Top Global Rare Disease Diagnostics Companies Ranked by Revenue (2021)
        4.1.2 Global Rare Disease Diagnostics Revenue by Player (2017-2022)
    4.2 Global Rare Disease Diagnostics Concentration Ratio (CR)
        4.2.1 Rare Disease Diagnostics Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Rare Disease Diagnostics in 2021
        4.2.3 Global Rare Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Rare Disease Diagnostics Headquarters, Revenue in Rare Disease Diagnostics Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Rare Disease Diagnostics Headquarters and Area Served
        4.3.2 Global Rare Disease Diagnostics Companies Revenue in Rare Disease Diagnostics Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Rare Disease Diagnostics Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Rare Disease Diagnostics Market Size by Company
        4.5.1 Top Rare Disease Diagnostics Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Rare Disease Diagnostics Revenue by Players (2020, 2021 & 2022)
5 Global Rare Disease Diagnostics Market Size by Region
    5.1 Global Rare Disease Diagnostics Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Rare Disease Diagnostics Market Size by Region (2017-2028)
        5.2.1 Global Rare Disease Diagnostics Market Size by Region: 2017-2022
        5.2.2 Global Rare Disease Diagnostics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Rare Disease Diagnostics Market Size YoY Growth 2017-2028
        6.1.2 North America Rare Disease Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Rare Disease Diagnostics Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Rare Disease Diagnostics Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Rare Disease Diagnostics Market Size YoY Growth 2017-2028
        6.3.2 Europe Rare Disease Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Rare Disease Diagnostics Market Size YoY Growth 2017-2028
        6.4.2 Latin America Rare Disease Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Rare Disease Diagnostics Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Rare Disease Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Retrophin
        7.1.1 Retrophin Company Details
        7.1.2 Retrophin Business Overview
        7.1.3 Retrophin Rare Disease Diagnostics Introduction
        7.1.4 Retrophin Revenue in Rare Disease Diagnostics Business (2017-2022)
        7.1.5 Retrophin Recent Development
    7.2 3billion
        7.2.1 3billion Company Details
        7.2.2 3billion Business Overview
        7.2.3 3billion Rare Disease Diagnostics Introduction
        7.2.4 3billion Revenue in Rare Disease Diagnostics Business (2017-2022)
        7.2.5 3billion Recent Development
    7.3 23andMe
        7.3.1 23andMe Company Details
        7.3.2 23andMe Business Overview
        7.3.3 23andMe Rare Disease Diagnostics Introduction
        7.3.4 23andMe Revenue in Rare Disease Diagnostics Business (2017-2022)
        7.3.5 23andMe Recent Development
    7.4 QIAGEN
        7.4.1 QIAGEN Company Details
        7.4.2 QIAGEN Business Overview
        7.4.3 QIAGEN Rare Disease Diagnostics Introduction
        7.4.4 QIAGEN Revenue in Rare Disease Diagnostics Business (2017-2022)
        7.4.5 QIAGEN Recent Development
    7.5 Illumina
        7.5.1 Illumina Company Details
        7.5.2 Illumina Business Overview
        7.5.3 Illumina Rare Disease Diagnostics Introduction
        7.5.4 Illumina Revenue in Rare Disease Diagnostics Business (2017-2022)
        7.5.5 Illumina Recent Development
    7.6 PerkinElmer
        7.6.1 PerkinElmer Company Details
        7.6.2 PerkinElmer Business Overview
        7.6.3 PerkinElmer Rare Disease Diagnostics Introduction
        7.6.4 PerkinElmer Revenue in Rare Disease Diagnostics Business (2017-2022)
        7.6.5 PerkinElmer Recent Development
    7.7 Strand Life Sciences
        7.7.1 Strand Life Sciences Company Details
        7.7.2 Strand Life Sciences Business Overview
        7.7.3 Strand Life Sciences Rare Disease Diagnostics Introduction
        7.7.4 Strand Life Sciences Revenue in Rare Disease Diagnostics Business (2017-2022)
        7.7.5 Strand Life Sciences Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Rare Disease Diagnostics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Rare Disease Diagnostics Market Trends
    Table 3. Rare Disease Diagnostics Market Drivers
    Table 4. Rare Disease Diagnostics Market Challenges
    Table 5. Rare Disease Diagnostics Market Restraints
    Table 6. Global Rare Disease Diagnostics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Rare Disease Diagnostics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Rare Disease Diagnostics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Rare Disease Diagnostics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Rare Disease Diagnostics Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Rare Disease Diagnostics Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Rare Disease Diagnostics Revenue Share by Player, 2017-2022
    Table 13. Global Rare Disease Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Rare Disease Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Disease Diagnostics as of 2021)
    Table 15. Top Players of Rare Disease Diagnostics in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Rare Disease Diagnostics Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Rare Disease Diagnostics Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Rare Disease Diagnostics Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Rare Disease Diagnostics Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Rare Disease Diagnostics Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Rare Disease Diagnostics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Rare Disease Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Rare Disease Diagnostics Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Rare Disease Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Rare Disease Diagnostics Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Rare Disease Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Rare Disease Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Rare Disease Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Retrophin Company Details
    Table 31. Retrophin Business Overview
    Table 32. Retrophin Rare Disease Diagnostics Product
    Table 33. Retrophin Revenue in Rare Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 34. Retrophin Recent Development
    Table 35. 3billion Company Details
    Table 36. 3billion Business Overview
    Table 37. 3billion Rare Disease Diagnostics Product
    Table 38. 3billion Revenue in Rare Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 39. 3billion Recent Development
    Table 40. 23andMe Company Details
    Table 41. 23andMe Business Overview
    Table 42. 23andMe Rare Disease Diagnostics Product
    Table 43. 23andMe Revenue in Rare Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 44. 23andMe Recent Development
    Table 45. QIAGEN Company Details
    Table 46. QIAGEN Business Overview
    Table 47. QIAGEN Rare Disease Diagnostics Product
    Table 48. QIAGEN Revenue in Rare Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 49. QIAGEN Recent Development
    Table 50. Illumina Company Details
    Table 51. Illumina Business Overview
    Table 52. Illumina Rare Disease Diagnostics Product
    Table 53. Illumina Revenue in Rare Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 54. Illumina Recent Development
    Table 55. PerkinElmer Company Details
    Table 56. PerkinElmer Business Overview
    Table 57. PerkinElmer Rare Disease Diagnostics Product
    Table 58. PerkinElmer Revenue in Rare Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 59. PerkinElmer Recent Development
    Table 60. Strand Life Sciences Company Details
    Table 61. Strand Life Sciences Business Overview
    Table 62. Strand Life Sciences Rare Disease Diagnostics Product
    Table 63. Strand Life Sciences Revenue in Rare Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 64. Strand Life Sciences Recent Development
    Table 65. Research Programs/Design for This Report
    Table 66. Key Data Information from Secondary Sources
    Table 67. Key Data Information from Primary Sources
List of Figures
    Figure 1. Rare Disease Diagnostics Product Picture
    Figure 2. Global Rare Disease Diagnostics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Rare Disease Diagnostics Market Size 2017-2028 (US$ Million)
    Figure 4. United States Rare Disease Diagnostics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Rare Disease Diagnostics Market Size 2017-2028 (US$ Million)
    Figure 6. United States Rare Disease Diagnostics Market Share in Global 2017-2028
    Figure 7. Rare Disease Diagnostics Report Years Considered
    Figure 8. Product Picture of Hematology
    Figure 9. Product Picture of Oncology
    Figure 10. Global Rare Disease Diagnostics Market Share by Type in 2022 & 2028
    Figure 11. Global Rare Disease Diagnostics Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Rare Disease Diagnostics Market Share by Type (2017-2028)
    Figure 13. United States Rare Disease Diagnostics Market Share by Type in 2022 & 2028
    Figure 14. United States Rare Disease Diagnostics Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Rare Disease Diagnostics Market Share by Type (2017-2028)
    Figure 16. Product Picture of Hospital Laboratories
    Figure 17. Product Picture of Diagnostic Laboratories
    Figure 18. Product Picture of Genetic Testing Laboratories
    Figure 19. Product Picture of Cancer Research Laboratories
    Figure 20. Product Picture of Others
    Figure 21. Global Rare Disease Diagnostics Market Share by Application in 2022 & 2028
    Figure 22. Global Rare Disease Diagnostics Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global Rare Disease Diagnostics Market Share by Application (2017-2028)
    Figure 24. United States Rare Disease Diagnostics Market Share by Application in 2022 & 2028
    Figure 25. United States Rare Disease Diagnostics Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States Rare Disease Diagnostics Market Share by Application (2017-2028)
    Figure 27. North America Rare Disease Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. U.S. Rare Disease Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada Rare Disease Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe Rare Disease Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany Rare Disease Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France Rare Disease Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. Rare Disease Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy Rare Disease Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia Rare Disease Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Rare Disease Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China Rare Disease Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan Rare Disease Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea Rare Disease Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India Rare Disease Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia Rare Disease Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Taiwan Rare Disease Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia Rare Disease Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand Rare Disease Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia Rare Disease Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Philippines Rare Disease Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Latin America Rare Disease Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 48. Mexico Rare Disease Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Brazil Rare Disease Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Argentina Rare Disease Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Rare Disease Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Turkey Rare Disease Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Rare Disease Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. U.A.E Rare Disease Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Retrophin Revenue Growth Rate in Rare Disease Diagnostics Business (2017-2022)
    Figure 56. 3billion Revenue Growth Rate in Rare Disease Diagnostics Business (2017-2022)
    Figure 57. 23andMe Revenue Growth Rate in Rare Disease Diagnostics Business (2017-2022)
    Figure 58. QIAGEN Revenue Growth Rate in Rare Disease Diagnostics Business (2017-2022)
    Figure 59. Illumina Revenue Growth Rate in Rare Disease Diagnostics Business (2017-2022)
    Figure 60. PerkinElmer Revenue Growth Rate in Rare Disease Diagnostics Business (2017-2022)
    Figure 61. Strand Life Sciences Revenue Growth Rate in Rare Disease Diagnostics Business (2017-2022)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Retrophin
3billion
23andMe
QIAGEN
Illumina
PerkinElmer
Strand Life Sciences
Frequently Asked Questions
Rare Disease Diagnostics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Rare Disease Diagnostics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Rare Disease Diagnostics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports